CA12 and hepatocellular carcinoma: Supporting this hypothesis, our data show that the upregulation of CA12 on tumor-associated macrophages could predict increased tumor metastatic potential and reduced survival of patients with HCC and that treatment with a CA12 inhibitor could effectively reduce tumor growth and metastasis in mice in vivo, presumably through attenuating the infiltration and functions of CA12-expressing macrophages.